S100A11 and neoplasm: Functional characterization revealed that S100A11, a key exosomal biomarker, promotes CRC progression in vitro by enhancing proliferation, and anti-apoptotic signaling, while its in vivo knockdown suppressed tumor growth, underscoring its oncogenic potency.